You may be eligible to participate in the CALIBRATE Study if you:lupus nephritis treatment options

  • Are male or female, aged 18+
  • Have been diagnosed with systemic lupus erythematosus
  • Have active proliferative lupus nephritis
  • Have previously been treated with either mycophenolate mofetil (CellCept®) or cyclophosphamide (Cytoxan®)

Find a CALIBRATE study location near you.